|
BOSTON, Dec. 13, 2016– Novaseek Research LLC, a health information technology for life sciences company, today announced that Kate Torchilin, PhD, MBA, Chief Executive Officer, will present at the upcoming Digital Medicine Showcase 2017, which takes place concurrently with the JP Morgan 35th Annual Healthcare Conference in San Francisco. Dr. Torchilin’s presentation will take place at 2:15 PM Pacific on Tuesday, January 10, at the Parc 55 San Francisco – Union Square.
In her presentation, Dr. Torchilin will provide an overview of Novaseek’s Clinical Data Network for Research (CDNR) platform and discuss how CDNR enables researchers turnkey access to clinical data and data-enriched, consented human biospecimens for use in real-world data and translational medicine studies in the areas of oncology, immune-oncology, cardiovascular disease, diabetes, neuroscience and more. She also will share how CDNR helps researchers define patient cohorts through population analytics and supports historical and longitudinal tracking and the collection of biospecimens and associated clinical data to stratify patients for studies. About Novaseek Novaseek Research LLC is a game-changing health IT for life sciences company that transforms how biomedical researchers access clinical data and human biospecimens for real-world data and precision medicine studies. Novaseek powers speedy and successful discovery, translational medicine, and real-world data studies by providing easy access to patients, longitudinal patient data and biospecimens via its award-winning Clinical Data Network for Research (CDNR) SaaS platform. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com. Media Contact: Terri Clevenger Continuum Health Communications tclevenger@continuumhealthcom.com (203) 856-4326 Comments are closed.
|
